recent publications
-
academic article
-
Cheong, H. Y., Groner, M., Hong, K., Lynch, B., Hollingsworth, W. R., Polonskaya, Z., Rhee, J. K., Baksh, M. M., Finn, M. G., Gale, A. J., Udit, A. K.
Heparin binding to an engineered virus-like nanoparticle antagonist
Biomacromolecules
2017
18:4113-4120
DOI:10.1021/acs.biomac.7b01174
PMID:28949131
-
Polonskaya, Z., Deng, S., Sarkar, A., Kain, L., Comellas-Aragones, M., McKay, C. S., Kaczanowska, K., Holt, M., McBride, R., Palomo, V., Self, K. M., Taylor, S., et al.
T cells control the generation of nanomolar-affinity anti-glycan antibodies
Journal of Clinical Investigation
2017
127:1491-1504
DOI:10.1172/jci91192
PMID:28287405
PMCID:PMC5373877
-
Nycholat, C. M., Peng, W., McBride, R., Antonopoulos, A., de Vries, R. P., Polonskaya, Z., Finn, M. G., Dell, A., Haslam, S. M., Paulson, J. C.
Synthesis of biologically active N- and O-linked glycans with multisialylated poly-N-acetyllactosamine extensions using P. damsela α2-6 sialyltransferase
Journal of the American Chemical Society
2013
135:18280-18283
DOI:10.1021/ja409781c
PMID:24256304
PMCID:PMC3901641
-
Gale, A. J., Elias, D. J., Averell, P. M., Teirstein, P. S., Buck, M., Brown, S. D., Polonskaya, Z., Udit, A. K., Finn, M. G.
Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients
Thrombosis Research
2011
128:E9-E13
DOI:10.1016/j.thromres.2011.03.021
PMID:21496885
PMCID:PMC3153569
- Gulevich, A. Y., Skorokhodova, A. Y., Ermishev, V. Y., Krylov, A. A., Minaeva, N. I., Polonskaya, Z. M., Zimenkov, D. V., Biryukova, I. V., Mashko, S. V. A new method for the construction of translationally coupled operons in a bacterial chromosome Molecular Biology 2009 43:505-514 DOI:10.1134/s0026893309030194
-